HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term efficacy of infliximab for treating Takayasu arteritis.

AuthorsZdenko Killinger, Daniel Cierny, Peter Jackuliak, Zuzana Zelinkova, Jozef Rovensky, Juraj Payer
JournalThe Israel Medical Association journal : IMAJ (Isr Med Assoc J) Vol. 14 Issue 12 Pg. 771-3 (Dec 2012) ISSN: 1565-1088 [Print] Israel
PMID23393718 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Adult
  • Antibodies, Monoclonal (administration & dosage)
  • Antirheumatic Agents (administration & dosage)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Takayasu Arteritis (drug therapy)
  • Time Factors
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: